3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
7
Glioma
5
Glioblastoma
4
Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
2
Prostatic Neoplasms
2
Ovarian Neoplasms
2
Oligodendroglioma
2
Gliosarcoma
2
Fallopian Tube Neoplasms
2
Central Nervous System Neoplasms
2
Breast Neoplasms
2
Brain Neoplasms
2
Astrocytoma
2
Uveal Melanoma
1
Urinary Bladder Neoplasms
1
Testicular Neoplasms
1
Skin Neoplasms
1
Sarcoma
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Pancreatic Neoplasms
1
Neuroectodermal Tumors, Primitive
1
Neoplasms, Plasma Cell
1
Myelodysplastic Syndromes
1
Metastatic Castration-resistant Prostate Cancer
1
Medulloblastoma
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Follicular
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Acute
1
Interventions
Ipilimumab
10
tremelimumab
6
durvalumab
5
Nivolumab
3
pembrolizumab
2
tilsotolimod
1
spartalizumab
1
relatlimab
1
folfirinox
1
balstilimab
1
Vemurafenib
1
Vaccines
1
Radiotherapy
1
Radiofrequency Ablation
1
Radiation
1
Paclitaxel
1
Oxaliplatin
1
Opdualag
1
Melphalan
1
Leucovorin
1
Fluorouracil
1
Docetaxel
1
Cryosurgery
1
Carboplatin
1
Capecitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Diabetes Mellitus, Insulin-Dependent, 12
×
poly ICLC
×
Clear all
No trials found.